CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +3,454 | $28.88 | $100K | 120,935 |
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +3,454 | $24.70 | $85K | 201,120 |
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +3,454 | $34.03 | $118K | 231,648 |
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +3,454 | $26.46 | $91K | 260,148 |
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +3,454 | $26.43 | $91K | 303,048 |
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +3,454 | $17.07 | $59K | 326,613 |
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −20,724 | $50.01 | $1.0M | 338,045 |
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,454 | 88,186 | ||
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,454 | 31,436 | ||
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,454 | 42,146 | ||
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,454 | 65,186 | ||
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,454 | 59,386 | ||
| 2024-05-28 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,454 | 91,506 | ||
| 2024-05-17 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −4,642 | $25.09 | $116K | 106,134 |
| 2024-05-17 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −5,945 | $25.09 | $149K | 149,275 |
| 2024-05-14 | Wise John Drayton Chief Commercial Officer | Sale | −5,088 | $25.47 | $130K | 123,259 |
| 2024-05-14 | Smith Michael Alexander Chief Legal Officer | Sale | −5,093 | $25.40 | $129K | 94,579 |
| 2024-05-14 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −6,508 | $25.53 | $166K | 108,760 |
| 2024-05-14 | Lewis William Chair and CEO | Sale | −22,198 | $25.52 | $566K | 384,125 |
| 2024-05-14 | Flammer Martina M.D. Chief Medical Officer | Sale | −10,640 | $25.47 | $271K | 110,776 |
Page 40 of 42 · 826 trades